跳至主要内容
临床试验/NCT04531163
NCT04531163Unknown2 期

Possible Ameliorating Effect of N- Acetylcysteine on Type-II Diabetes Induced Nephropathy

Al-Azhar University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
60
试验地点
1
主要终点
Lipoprotein (a)

研究概览

简要总结

The study is focused on the possible improving effect of N-acetylcysteine on nephropathy of type-2 diabetic patients.

Study design: Prospective clinical based study. The aim of this work is to study the effect of N-acetylcysteine (NAC) on proteinuria and on the serum level of lipoprotein a (LPa) in diabetes induced nephropathy in type-2 diabetic patients.

详细描述

This study will be carried on 60 participants with Type 2 Diabetes with age over 20 years.

Participants will be classified into two groups:

  1. Group I (Interventional): treated with (NAC) dose of 1200 mg/day for two months in conjunction with conventional treatment.
  2. Group II (Non-interventional): control group receive conventional treatment.

All patients will undergo the following:

  1. Full medical history will be taken.
  2. Laboratory investigations as follows:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

All participants,investigators, care providers, and outcome assessor have knowledge of the interventions assigned to individual participants.

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis of Diabetes Mellitus.
  • Age over 20 years.
  • Patients with proteinuria ≥ 30 mg /dl.

排除标准

  • Patients on lipid lowering medications.
  • Cigarette smokers.
  • Presence of liver and heart diseases.

研究组 & 干预措施

Interventional

Experimental

First arm is experimental, given (NAC) for 2 months in 1200mg/day dosing.

Both arms are assigned to pre-treatment analytical tests and post treatment all test analysis are repeated to compare drug effect with placebo group.

干预措施: N Acetylcysteine (Drug)

结局指标

主要结局

Lipoprotein (a)

时间窗: 2 months

unique lipoprotein that has emerged as an independent risk factor for developing vascular disease.

Systolic blood pressure

时间窗: 2 months

The first number of blood pressure reading and it indicates how much pressure our blood is exerting against our artery walls when the heart beats. It is a major risk factor for cardiovascular disease.

Triglycerides

时间窗: 2 months

Triglycerides are a type of fat (lipid) found in our blood. It is one of the lipid panel used to determine atherosclerotic risk that contributes to vascular diseases.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tasneem Ahmed Hamed

Clinical pharamacist

Al-Azhar University

研究点 (1)

Loading locations...

相似试验

Possible Ameliorating Effect of N- Acetylcysteine... | 临床试验